Celgene Corp. buy piccolo90
Start price
16.12.16
/
50%
€105.69
Target price
24.01.17
€125.41
Performance (%)
-4.42%
End price
24.01.17
€101.02
Summary
This prediction ended on 24.01.17 with a price of €101.02. With a performance of -4.42%, the BUY prediction by piccolo90 finished with a loss. piccolo90 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -1.665% | -10.870% | -0.717% | 41.869% |
| iShares Nasdaq 100 | -3.766% | -5.147% | 13.412% | 70.295% |
| iShares Nikkei 225® | -2.803% | -11.299% | 25.461% | 45.956% |
| iShares S&P 500 | -2.299% | -4.801% | 8.938% | 54.178% |
Comments by piccolo90 for this prediction
In the thread Celgene Corp. diskutieren
piccolo90 stimmt der Outperform-Einschätzung der institutionellen Analysten zu
piccolo90 stimmt am 16.12.2016 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 139.04$ zu.
(Vom Mitglied beendet)